Results 171 to 180 of about 21,492 (283)

Inter‐Ethnic Differences in the Efficacy and Safety of Tyrosine Kinase Inhibitors Used in Oncology: Insights From Phase 3 Clinical Trials

Clinical and Translational Science, Volume 18, Issue 5, May 2025.
ABSTRACT Differences in the efficacy and safety of tyrosine kinase inhibitors (TKIs) have been observed across ethnic/ancestry subpopulations (previously reviewed to 2017). With an expanding number of TKIs approved since that time, an updated review of TKI response across ethnic/ancestry subpopulations in Phase 3 TKI clinical trials was conducted.
Nicki M. Kyriacou, Annette S. Gross, Andrew J. McLachlan   +2 more
wiley   +1 more source

AFP-producing Intrahepatic Bile Duct Cancer with Difficulty in Differentiation from Hepatocellular Carcinoma.

, 2001
Kazuya Sonoda, Kengo Fukuzawa, Tadahiko Kinoshita, Kenji Takenaka   +3 more
openalex   +2 more sources

Association between diabetes self‐management education attendance, hospital admissions and mortality in type 2 diabetes: A cohort analysis protocol

Diabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2377-2386, May 2025.
Abstract Introduction Type 2 diabetes is associated with excess hospital admissions and increased mortality. Structured diabetes self‐management education (DSME) is recommended internationally and is associated with improved self‐management skills, well‐being and minor improvements in glycated haemoglobin (HBA1c), but does it reduce hospital admissions
Gemma A. Lewis, David M. Hughes, Greg Irving, John Wilding, Kevin Hardy   +4 more
wiley   +1 more source

A Case of Congenital Dilatation of the Bile Duct with Cystic Dilatation of the Intrahepatic Bile Duct.

, 2001
Yoko Tanimura, Shinichi Mizuno, Eiichi Asano, Hideki Shimoji   +3 more
openalex   +2 more sources

Clinicopathological features of the intraductal papillary neoplasms of the intrahepatic bile duct [PDF]

, 2012
Gi-Woong Jang, Shin Hwang, Yong-Joo Lee, Ki‐Hun Kim, Kwang‐Min Park, Chul‐Soo Ahn, Deok‐Bog Moon, Tae‐Yong Ha, Gi‐Won Song, Dong‐Hwan Jung, Gil‐Chun Park, Sung‐Gyu Lee   +11 more
openalex   +1 more source

Ursodeoxycholic Acid Alone Is Effective and Safe to Treat Cholestatic Checkpoint Inhibitor‐Induced Liver Injury

Liver International, Volume 45, Issue 5, May 2025.
ABSTRACT Introduction Checkpoint Inhibitor‐induced Liver Injury (CHILI) is a frequent complication of immune checkpoint inhibitors (ICIs). Corticosteroids are the standard treatment but have many limitations. Ursodeoxycholic acid (UDCA) offers an alternative for managing cholestatic CHILI, but its efficacy remains underexplored.
Lina Hountondji, Stéphanie Faure, Pascale Palassin, Georges‐Philippe Pageaux, Alexandre Thibault Jacques Maria, Lucy Meunier   +5 more
wiley   +1 more source

Systemic Icterus in Two Aged Cattle Resulting from Incomplete Obstruction in the Common Bile Duct by Intrahepatic Cholangiocarcinoma

, 2003
Yusuke Mizutani, T. Morita, Masumi Sawada, Akinori Shimada, Kota Sato, Yoshiaki Hikasa   +5 more
openalex   +2 more sources

Bile Duct Leaks from the Intrahepatic Biliary Tree: A Review of Its Etiology, Incidence, and Management [PDF]

, 2012
Sorabh Kapoor, Samiran Nundy
openalex   +1 more source

Specific effects on liver relevant for performing a dietary cumulative risk assessment of pesticide residues

EFSA Journal, Volume 23, Issue 5, May 2025.
Abstract According to the ‘EFSA‐SANTE Action Plan on Cumulative Risk Assessment for pesticides residues’, EFSA initiated a retrospective cumulative risk assessment (CRA) of the effects of pesticide residues on the liver. For this CRA, EFSA identified the following liver‐specific effects in accordance with the International Harmonisation of Nomenclature
European Food Safety Authority (EFSA), Anna F. Castoldi, Tamara Coja, Anna Lanzoni, Kyriaki Machera, Luc Mohimont, Monica Nepal, Camilla Recordati, Federica Crivellente   +8 more
wiley   +1 more source

Ultrasound of Bile Ducts-An Update on Measurements, Reference Values, and Their Influencing Factors. [PDF]

Diagnostics (Basel)
Lucius C, Flückiger A, Meier J, Möller K, Jenssen C, Braden B, Kallenbach M, Misselwitz B, Nolsøe C, Sienz M, Zervides C, Dietrich CF.   +11 more
europepmc   +1 more source